DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Chen YM, Chen HH, Chen YH. et al.
comparison of safety profiles of tumour necrosis factor α inhibitors and rituximab therapy in patients with rheumatoid arthritis and chronic hepatitis C.
Ann Rheum Dis 2015;
74: 626-627
We do not assume any responsibility for the contents of the web pages of other providers.